Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

160 results about "Control subjects" patented technology

In an experiment or clinical trial, control subjects make up a group of participants who have characteristics similar to those of the treatment group, but they do not receive the treatment being studied. In an observational study, the control subjects have similar characteristics as those participants being studied,...

Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity

The methods described herein enable the evaluation of compounds on subjects to assess their therapeutic efficacy or toxic effects. The target of analysis is the underlying biochemical process or processes (i.e., metabolic process) thought to be involved in disease pathogenesis. Molecular flux rates within the one or more biochemical processes serve as biomarkers and are quantitated and compared with the molecular flux rates (i.e., biomarker) from control subjects (i.e., subjects not exposed to the compounds). Any change in the biomarker in the subject relative to the biomarker in the control subject provides the necessary information to evaluate therapeutic efficacy of an administered drug or a toxic effect and to develop the compound further if desired. In one aspect of the invention, stable isotope-labeled substrate molecules are administered to a subject and the label is incorporated into targeted molecules in a manner that reveals molecular flux rates through one or more metabolic pathways of interest. By this method, a comparison between subjects and control subjects reveals the effects of the chemical entity or entities on the biomarkers. This, in turn, allows for the identification of potential therapeutic uses or toxicities of the compound. Combinations of compounds can also be systematically evaluated for complementary, synergistic, or antagonistic actions on the metabolic pathways of interest, using the methods of the present invention as a strategy for identifying and confirming novel therapeutic or toxic combinations of compounds.
Owner:RGT UNIV OF CALIFORNIA

Visual point burying method for cross-platform mobile terminal

ActiveCN108304176AAdded custom dimension function for buried pointsSoftware testing/debuggingVisual/graphical programmingControl subjectsRelevant information
The invention discloses a visual point burying method for a cross-platform mobile terminal. The method comprises the steps that control tree related information sent to a current interactive interfaceof a server is refreshed after a client establishes a connection with the server; the server synchronously updates a rendering interface according to the received information, and a user performs visual point burying selection operation on a control in the server; a binding condition of the control is tested, the server sends point burying information to the client, and the client confirms the control specified in the obtained point burying information and performs binding; the test of the bound control is triggered in the client, event information of the control is triggered and sent to theserver, and after the test is passed, the server performs deployment operation on the control subjected to point burying and selection. A point burying dimension self-definition function is added; thesupport of point burying of HTML elements is added; the interactive interface control is universally used for various self-defined client interactive interfaces; and for the webpage control, a visualcode injection point burying function and a similar element point burying function are supported.
Owner:广东数果科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products